We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
356 result(s) found, displaying 161 to 170
-
Designation or determinationOrphan drug
-
Designation or determinationProvisional approval
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg film-coated tablet blister pack.
-
Designation or determinationOrphan drug